Establishment Labs Reports Strong Q1 Results, Raises Full-Year Revenue Guidance
Summary
Establishment Labs reported strong Q1 2026 financial results, including significant revenue growth and positive Adjusted EBITDA, leading to an upward revision of its full-year revenue guidance and a projected free cash flow positive second half.
Key Events
-
Strong Q1 2026 Financial Performance
Reported revenue of $59.9 million, a 44.7% increase from Q1 2025, with gross margin improving to 70.7% from 67.2% in the prior-year period. Loss from operations significantly reduced to $6.5 million from $16.9 million.
-
Achieved Positive Adjusted EBITDA
Reported Adjusted EBITDA income of $1.2 million for Q1 2026, a substantial improvement from a $12.1 million loss in the year-ago period, marking the third consecutive quarter of positive Adjusted EBITDA.
-
Raised Full-Year 2026 Guidance
Increased full-year revenue guidance to a range of $266.5 million to $268.5 million, up from the previous range of $264 million to $266 million. Guidance for the minimally invasive business was also raised to exceed $35 million.
-
Path to Free Cash Flow Positive
The company expects to be free cash flow positive in the second half of 2026, further enhancing its financial stability.
Analysis
Establishment Labs Holdings Inc. reported robust first-quarter results, demonstrating significant operational leverage and strong growth. The company achieved a 44.7% year-over-year revenue increase and notably shifted to a positive Adjusted EBITDA of $1.2 million, marking its third consecutive quarter of positive Adjusted EBITDA. This strong performance has led management to raise its full-year 2026 revenue guidance and increase expectations for its minimally invasive business. The improved financial outlook, coupled with the recently secured $300 million credit facility on April 30, 2026, significantly enhances the company's financial flexibility and provides a clear path to becoming free cash flow positive in the second half of the year. This filing indicates a positive trajectory for the company's financial health and growth strategy.
At the time of this filing, ESTA was trading at $73.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $32.25 to $83.31. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.